Vancomycin-resistant enterococci - A road map on how to prevent the emergence and transmission of antimicrobial resistance

被引:71
作者
DeLisle, S
Perl, TM
机构
[1] US Vet Adm Med Ctr, Baltimore, MD USA
[2] Univ Maryland, Dept Internal Med, Baltimore, MD 21201 USA
[3] Univ Maryland, Dept Physiol, Div Pulm & Crit Care, Baltimore, MD 21201 USA
[4] Johns Hopkins Univ, Sch Med, Dept Hosp Epidemiol, Baltimore, MD USA
[5] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[6] Johns Hopkins Univ, Bloomberg Sch Publ Hlth & Hyg, Baltimore, MD 21205 USA
关键词
antibiotic control; antibiotic management; antibiotic stewardship; enterococcus; infection control; resistance; review; surveillance; vancomycin; vancomycin-resistant enterococci;
D O I
10.1378/chest.123.5_suppl.504S
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Nosocomial acquisition of microorganisms resistant to multiple antibiotics represents a threat to patient safety. Here we review the mechanisms that have allowed highly resistant strains belonging to the Enterococcus genus to proliferate within our health-care institutions. These mechanisms indicate that decreasing the prevalence of resistant organisms requires active surveillance, adherence to vigorous isolation, hand hygiene and environmental decontamination measures, and effective antibiotic stewardship. We suggest how to tailor such a complex, multidisciplinary program to the needs of a particular health-care setting so as to maximize cost-effectiveness.
引用
收藏
页码:504S / 518S
页数:15
相关论文
共 183 条
[1]   Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the vanA cluster [J].
Aarestrup, FM ;
Ahrens, P ;
Madsen, M ;
Pallesen, LV ;
Poulsen, RL ;
Westh, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (08) :1938-1940
[2]   Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (quinupristin-dalfopristin) administered by intermittent or continuous infusion, alone or in combination with doxycycline, in an in vitro pharmacodynamic infection model with simulated endocardial vegetations [J].
Aeschlimann, JR ;
Zervos, MJ ;
Rybak, MJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) :2710-2717
[3]   Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium [J].
Anglim, AM ;
Klym, B ;
Byers, KE ;
Scheld, WM ;
Farr, BM .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (10) :1132-1136
[4]  
[Anonymous], 1995, INFECT CONT HOSP EP, V16, P105
[5]  
[Anonymous], 1993, MMWR-MORBID MORTAL W, V42, P597
[6]   Antimicrobial resistance in isolates from inpatients and outpatients in the united states: Increasing importance of the intensive care unit [J].
Archibald, L ;
Phillips, L ;
Monnet, D ;
McGowan, JE ;
Tenover, F ;
Gaynes, R .
CLINICAL INFECTIOUS DISEASES, 1997, 24 (02) :211-215
[7]   GENETICS AND MECHANISMS OF GLYCOPEPTIDE RESISTANCE IN ENTEROCOCCI [J].
ARTHUR, M ;
COURVALIN, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (08) :1563-1571
[8]   Selection of glycopeptide-resistant mutants of VanB-type Enterococcus faecalis BM4281 in vitro and in experimental endocarditis [J].
Aslangul, E ;
Baptista, M ;
Fantin, B ;
Depardieu, F ;
Arthur, M ;
Courvalin, P ;
Carbon, C .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (03) :598-605
[9]   Outpatient vancomycin use and vancomycin-resistant enterococcal colonization in maintenance dialysis patients [J].
Atta, MG ;
Eustace, JA ;
Song, XY ;
Perl, TM ;
Scheel, PJ .
KIDNEY INTERNATIONAL, 2001, 59 (02) :718-724
[10]   The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance [J].
Austin, DJ ;
Kristinsson, KG ;
Anderson, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (03) :1152-1156